A 19-year old Nebraska woman and her mother face jail time on charges stemming from a self-managed abortion in a case Dean Rachel Rebouche calls “potentially a signal of some really disturbing things to come.” Read More

The FDA has approved the first over-the-counter birth control pill, easing access to contraceptives in what Dean Rebouche calls a “crucial moment in the US.” Read More

Dean Rebouche and co-authors David S. Cohen and Greer Donley call for abortion-rights supporters to begin the work of overturning Dobbs. “If ever there was a time for hope and for a strategy directly targeting Dobbs, this is it.” Read More

ne year since the end of Roe, Dean Rebouche reflects on the emergence of new allies for the abortion rights movement. Read More

As America approaches the first anniversary of Dobbs v. Jackson, the landscape of state abortion laws remains confusing and chaotic. Dean Rebouche says that’s no surprise. Read More

As New York joins other states in shielding abortion providers from prosecution, questions remain about civil liability or licensure risks. Dean Rebouche says it’s a matter of when, not if, providers are challenged in court. Read More

With all eyes on a Texas order limiting FDA authority over abortion pills, Dean Rebouche discusses two cases making the opposite claim – that FDA regulations preempt conflicting state laws. Read More

Dean Rebouche says no court has ruled on the scope of the Comstock Act, a pillar of anti-abortion strategy, likely sending abortion “right back to the Supreme Court.” Read More

Dean Rebouche pushes back against the “widespread conflation of discretion and defiance” regarding the FDA’s enforcement discretion should its approval of mifepristone be rolled back. Read More

A new generation of anti-abortion activists is not afraid to lose short-term battles in pursuit of their long-term goal: eliminating abortion from the country, says Dean Rachel Rebouche. Read More